Five key molecules (CHST4, SLC22A8, STC2, hsa-miR-326, and hsa-miR-21) serve as potential prognostic markers for HCC potentially through regulation of p53 and FoxO signaling patheways. This evidence concerns the gene SLC22A8 and hepatocellular carcinoma.